Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18 F-flutemetamol positron emission tomography
ConclusionAmyloid PET tracers such as18F-flutemetamol could be a promising tool in diagnosing and in therapy response assessment for patients with cardiac amyloidosis.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Amyloidosis | Cardiology | Genetics | Heart | Nuclear Medicine | PET Scan | Rare Diseases | Study